| Lastest Insider Transactions Of Mineralys Therapeutics, Inc. ( MLYS ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2025-11-21 | Option Exercise | 24,082 | 0.54 | 13,004 | 2025-11-24 17:07:17 |
| MLYS | Mineralys Therapeutics, Inc. | Slingsby Brian Taylor | Directior 10% Owner | 2025-11-20 | Sell | 1,000,000 | 43.35 | 43,350,000 | 2025-11-21 18:07:59 |
| MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | 2025-11-11 | Sell | 119,524 | 44.88 | 5,363,716 | 2025-11-13 19:01:37 |
| MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | 2025-11-11 | Option Exercise | 105,653 | 14.11 | 1,490,434 | 2025-11-13 19:01:37 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2025-11-11 | Sell | 200,000 | 45.44 | 9,088,499 | 2025-11-13 19:01:30 |
| MLYS | Mineralys Therapeutics, Inc. | Karydas Daphne | Directior | 2025-11-13 | Sell | 15,000 | 45.99 | 689,797 | 2025-11-13 19:01:24 |
| MLYS | Mineralys Therapeutics, Inc. | Karydas Daphne | Directior | 2025-11-13 | Option Exercise | 15,000 | 10.20 | 153,000 | 2025-11-13 19:01:24 |
| MLYS | Mineralys Therapeutics, Inc. | Gold Alexander M | Directior | 2025-11-11 | Sell | 34,675 | 45.45 | 1,576,095 | 2025-11-13 19:01:18 |
| MLYS | Mineralys Therapeutics, Inc. | Gold Alexander M | Directior | 2025-11-11 | Option Exercise | 34,675 | 10.92 | 378,585 | 2025-11-13 19:01:18 |
| MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | 2025-10-13 | Sell | 10,758 | 42.01 | 451,984 | 2025-10-15 19:04:39 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2025-10-13 | Sell | 15,100 | 42.67 | 644,327 | 2025-10-15 19:04:33 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-10-15 | Sell | 10,369 | 43.01 | 445,982 | 2025-10-15 19:04:27 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-09-15 | Sell | 11,367 | 36.00 | 409,266 | 2025-09-16 18:54:38 |
| MLYS | Mineralys Therapeutics, Inc. | AKKARAJU SRINIVAS | Directior | 2025-09-04 | Buy | 588,235 | 25.50 | 14,999,992 | 2025-09-08 20:07:14 |
| MLYS | Mineralys Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Directior | 2025-09-04 | Buy | 1,176,470 | 25.50 | 29,999,984 | 2025-09-08 17:59:46 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-08-12 | Sell | 11,365 | 12.93 | 146,987 | 2025-08-14 18:02:58 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-08-12 | Option Exercise | 6,349 | 1.08 | 6,857 | 2025-08-14 18:02:58 |
| MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | 2025-07-28 | Sell | 73,678 | 14.62 | 1,077,477 | 2025-07-30 20:12:01 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2025-07-11 | Sell | 15,884 | 14.51 | 230,431 | 2025-07-15 17:02:38 |
| MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | 2025-07-11 | Sell | 10,758 | 14.45 | 155,454 | 2025-07-15 17:01:27 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-07-14 | Sell | 11,366 | 14.59 | 165,879 | 2025-07-15 17:00:35 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-07-14 | Option Exercise | 6,349 | 1.08 | 6,857 | 2025-07-15 17:00:35 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-06-12 | Sell | 11,366 | 14.60 | 165,931 | 2025-06-16 16:03:20 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-06-12 | Option Exercise | 6,348 | 1.08 | 6,856 | 2025-06-16 16:03:20 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-05-14 | Sell | 11,366 | 15.29 | 173,774 | 2025-05-15 19:01:41 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-05-12 | Option Exercise | 6,349 | 1.08 | 6,857 | 2025-05-13 20:57:09 |
| MLYS | Mineralys Therapeutics, Inc. | Slingsby Brian Taylor | Directior 10% Owner | 2025-03-13 | Buy | 259,259 | 13.50 | 3,499,997 | 2025-04-25 19:01:59 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-04-14 | Sell | 11,366 | 14.53 | 165,185 | 2025-04-15 20:39:20 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-04-14 | Option Exercise | 6,348 | 1.08 | 6,856 | 2025-04-15 20:39:20 |
| MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | 2025-04-11 | Sell | 10,757 | 12.06 | 129,684 | 2025-04-15 20:36:00 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2025-04-11 | Sell | 15,319 | 12.19 | 186,803 | 2025-04-15 20:33:35 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-04-01 | Sell | 55,771 | 15.76 | 879,009 | 2025-04-03 17:36:57 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-04-01 | Option Exercise | 1,606 | 1.08 | 1,734 | 2025-04-03 17:36:57 |
| MLYS | Mineralys Therapeutics, Inc. | Samsara BioCapital GP, LLC | 10% Owner | 2025-03-13 | Buy | 600,000 | 13.50 | 8,100,000 | 2025-03-17 21:05:47 |
| MLYS | Mineralys Therapeutics, Inc. | AKKARAJU SRINIVAS | Directior | 2025-03-13 | Buy | 600,000 | 13.50 | 8,100,000 | 2025-03-17 21:04:15 |
| MLYS | Mineralys Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Directior | 2025-03-13 | Buy | 1,296,296 | 13.50 | 17,499,996 | 2025-03-17 19:56:53 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-03-12 | Option Exercise | 6,349 | 1.08 | 6,857 | 2025-03-13 17:15:40 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-02-12 | Option Exercise | 6,348 | 1.08 | 6,856 | 2025-02-13 17:29:35 |
| MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | 2025-01-13 | Sell | 10,757 | 9.10 | 97,864 | 2025-01-15 21:46:09 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2025-01-13 | Option Exercise | 11,367 | 0.84 | 9,567 | 2025-01-15 21:45:31 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2025-01-13 | Sell | 18,333 | 9.06 | 166,082 | 2025-01-15 21:44:54 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-12-11 | Option Exercise | 5,017 | 0.54 | 2,709 | 2024-12-13 16:37:02 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-11-11 | Sell | 5,026 | 15.00 | 75,398 | 2024-11-12 17:25:38 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-11-11 | Option Exercise | 10,043 | 0.81 | 8,137 | 2024-11-12 17:25:38 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-11-06 | Sell | 25,482 | 15.03 | 383,066 | 2024-11-08 16:21:39 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-11-06 | Option Exercise | 25,482 | 1.08 | 27,521 | 2024-11-08 16:21:39 |
| MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | 2024-10-11 | Sell | 10,757 | 13.57 | 146,004 | 2024-10-15 16:22:25 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-10-11 | Option Exercise | 10,369 | 0.82 | 8,489 | 2024-10-15 16:22:13 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2024-10-11 | Sell | 15,271 | 13.52 | 206,433 | 2024-10-15 16:21:57 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-09-11 | Option Exercise | 11,367 | 0.84 | 9,567 | 2024-09-12 16:32:12 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-08-12 | Option Exercise | 11,365 | 0.84 | 9,565 | 2024-08-13 16:20:30 |
| MLYS | Mineralys Therapeutics, Inc. | Slingsby Brian Taylor | Directior 10% Owner | 2024-07-24 | Sell | 550,000 | 13.05 | 7,177,500 | 2024-07-26 21:45:51 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-07-16 | Sell | 525 | 15.00 | 7,876 | 2024-07-18 18:34:08 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-07-16 | Option Exercise | 525 | 1.08 | 567 | 2024-07-18 18:34:08 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-07-11 | Option Exercise | 11,366 | 0.84 | 9,566 | 2024-07-12 16:39:06 |
| MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | 2024-07-11 | Sell | 10,757 | 13.14 | 141,394 | 2024-07-12 16:37:59 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2024-07-11 | Sell | 15,746 | 13.34 | 210,075 | 2024-07-12 16:36:46 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2024-06-17 | Sell | 49,313 | 12.01 | 592,022 | 2024-06-20 17:44:01 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2024-06-12 | Sell | 72,797 | 12.70 | 924,203 | 2024-06-14 18:15:49 |
| MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | 2024-06-11 | Sell | 96,815 | 12.94 | 1,252,718 | 2024-06-13 17:33:32 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-06-11 | Option Exercise | 11,366 | 0.84 | 9,566 | 2024-06-13 17:32:09 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-05-13 | Option Exercise | 11,366 | 0.84 | 9,566 | 2024-05-15 16:43:17 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-05-09 | Sell | 100 | 15.00 | 1,500 | 2024-05-10 16:17:37 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-05-09 | Option Exercise | 100 | 1.08 | 108 | 2024-05-10 16:17:37 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-04-11 | Option Exercise | 11,366 | 0.84 | 9,566 | 2024-04-15 16:24:49 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-03-11 | Option Exercise | 11,365 | 0.84 | 9,565 | 2024-03-13 17:35:35 |
| MLYS | Mineralys Therapeutics, Inc. | Samsara BioCapital GP, LLC | 10% Owner | 2024-02-12 | Buy | 555,555 | 13.50 | 7,499,993 | 2024-02-14 21:06:11 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-02-12 | Option Exercise | 11,366 | 0.84 | 9,566 | 2024-02-13 16:08:54 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-01-11 | Option Exercise | 11,365 | 0.84 | 9,565 | 2024-01-12 16:01:35 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2023-12-11 | Option Exercise | 5,018 | 0.54 | 2,710 | 2023-12-12 17:08:45 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2023-11-22 | Buy | 4,250 | 5.97 | 25,356 | 2023-11-27 16:01:13 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2023-11-13 | Option Exercise | 5,017 | 0.54 | 2,709 | 2023-11-14 18:18:43 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2023-11-03 | Option Exercise | 10,034 | 0.54 | 5,418 | 2023-11-07 17:15:39 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2023-09-06 | Buy | 2,250 | 12.08 | 27,180 | 2023-09-08 08:49:26 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2023-08-17 | Buy | 2,250 | 12.10 | 27,225 | 2023-08-21 16:03:20 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2023-08-10 | Sell | 231,716 | 12.92 | 2,994,401 | 2023-08-11 19:11:30 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2023-08-10 | Option Exercise | 231,716 | 0.72 | 166,265 | 2023-08-11 19:11:30 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2023-08-11 | Buy | 2,000 | 12.89 | 25,780 | 2023-08-11 19:11:15 |
| MLYS | Mineralys Therapeutics, Inc. | HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | 2023-02-14 | Buy | 312,500 | 16.00 | 5,000,000 | 2023-02-16 21:00:28 |
| MLYS | Mineralys Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Directior | 2023-02-14 | Buy | 1,250,000 | 16.00 | 20,000,000 | 2023-02-16 17:04:34 |
| MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Chief Bus. Off. and Secy. | 2023-02-14 | Buy | 6,250 | 16.00 | 100,000 | 2023-02-16 16:54:40 |
| MLYS | Mineralys Therapeutics, Inc. | AKKARAJU SRINIVAS | Directior 10% Owner | 2023-02-14 | Buy | 937,500 | 16.00 | 15,000,000 | 2023-02-16 16:54:22 |
| MLYS | Mineralys Therapeutics, Inc. | Slingsby Brian Taylor | Directior 10% Owner | 2023-02-14 | Buy | 250,000 | 16.00 | 4,000,000 | 2023-02-16 16:54:03 |
